Teva Pharmaceutical Industries Limited
TEVA
|
|
| |
|
| Trading Volume | 195,765 |
|
|
18.75 - 8.13 |
| Market Cap Full | $ 21B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -3.6% | 35% | -3.1% | 17.2% |
| Q2 | - | 17% | -14.9% | -19.9% |
| Q3 | - | 7.5% | 35.6% | 7.3% |
| Q4 | - | 26.9% | 4.5% | 13.1% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.6 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 15.9 | 8.4 | 7.4 | -8.8 | 31.6 | -3.8 | 7.1 | 7.5 | - | - | - | 31.4 |
| 2023 | |||||||||||
| 15.5 | -6 | -10.8 | -1.4 | -17.6 | 4.7 | 11.6 | 16.3 | 4.5 | -15.9 | 14.6 | 6.3 |
| 2022 | |||||||||||
| 5.2 | -4.1 | 16.1 | -7.2 | 4.5 | -17.4 | 24.7 | -3.6 | -10.7 | 10.5 | -1.7 | 4.1 |
| 2021 | |||||||||||
| 22.1 | -8.7 | 7.3 | -7.3 | -2.8 | -4.8 | -2.8 | -2.1 | 3.4 | -10.3 | -5.6 | -2.9 |
| 2020 | |||||||||||
| 4.2 | 10.9 | -22.1 | 19.6 | 16.7 | -1.6 | -6.4 | -14.5 | -8.7 | -3.2 | 10.6 | 0.1 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.9 | 0.1 | 0.1 |
| Q2 | -0.8 | -0.2 | 0.2 | 0.1 |
| Q3 | 0.1 | 0.1 | 0.3 | -4 |
| Q4 | 0 | -1.1 | -0.1 | 0.1 |
| A | -0.88 | -2.1 | 0.4 | -3.6 |